Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis
G Shen, H Deng, S Hu, Z Jia - Skeletal radiology, 2014 - Springer
Published data on the diagnosis of bone metastases of prostate cancer are conflicting and
heterogeneous. We performed a comprehensive meta-analysis to compare the diagnostic …
heterogeneous. We performed a comprehensive meta-analysis to compare the diagnostic …
Skeletal PET with 18F-fluoride: applying new technology to an old tracer
FD Grant, FH Fahey, AB Packard… - Journal of nuclear …, 2008 - Soc Nuclear Med
Although 18F-labeled NaF was the first widely used agent for skeletal scintigraphy, it quickly
fell into disuse after the introduction of 99mTc-labeled bone-imaging agents. Recent …
fell into disuse after the introduction of 99mTc-labeled bone-imaging agents. Recent …
Comparison of bone scintigraphy and 68Ga-PSMA PET for skeletal staging in prostate cancer
T Pyka, S Okamoto, M Dahlbender, R Tauber… - European journal of …, 2016 - Springer
Purpose The aim of our study was to compare the diagnostic performance of 68 Ga-PSMA
PET and 99m Tc bone scintigraphy (BS) for the detection of bone metastases in prostate …
PET and 99m Tc bone scintigraphy (BS) for the detection of bone metastases in prostate …
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology
Objectives: With combined positron emission tomography and computed tomography (CT),
we investigated coronary arterial uptake of 18F-sodium fluoride (18F-NaF) and 18F …
we investigated coronary arterial uptake of 18F-sodium fluoride (18F-NaF) and 18F …
Comparison of PSMA-PET/CT, choline-PET/CT, NaF-PET/CT, MRI, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a …
J Zhou, Z Gou, R Wu, Y Yuan, G Yu, Y Zhao - Skeletal radiology, 2019 - Springer
Objective A systematic review and meta-analysis to compare the diagnostic performance of
prostate-specific membrane antigen (PSMA)-PET/CT, choline-PET/CT, Sodium Fluoride …
prostate-specific membrane antigen (PSMA)-PET/CT, choline-PET/CT, Sodium Fluoride …
SNM practice guideline for sodium 18F-fluoride PET/CT bone scans 1.0
G Segall, D Delbeke, MG Stabin… - Journal of Nuclear …, 2010 - Soc Nuclear Med
The Society of Nuclear Medicine (SNM) is an international scientific and professional
organization founded in 1954 to promote the science, technology, and practical application …
organization founded in 1954 to promote the science, technology, and practical application …
Diagnosis of bone metastases: a meta-analysis comparing 18FDG PET, CT, MRI and bone scintigraphy
HL Yang, T Liu, XM Wang, Y Xu, SM Deng - European radiology, 2011 - Springer
Objective To perform a meta-analysis to compare 18 FDG PET, CT, MRI and bone
scintigraphy (BS) for the diagnosis of bone metastases. Methods Databases including …
scintigraphy (BS) for the diagnosis of bone metastases. Methods Databases including …
[HTML][HTML] Bone metastasis classification using whole body images from prostate cancer patients based on convolutional neural networks application
Bone metastasis is one of the most frequent diseases in prostate cancer; scintigraphy
imaging is particularly important for the clinical diagnosis of bone metastasis. Up to date …
imaging is particularly important for the clinical diagnosis of bone metastasis. Up to date …
Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of …
FE Lecouvet, J El Mouedden, L Collette, E Coche… - European urology, 2012 - Elsevier
BACKGROUND: Technetium Tc 99m bone scintigraphy (BS) and contrast-enhanced
computed tomography (CT) or magnetic resonance imaging (MRI) of the pelvis and …
computed tomography (CT) or magnetic resonance imaging (MRI) of the pelvis and …
Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with …
SY Cho, KL Gage, RC Mease… - Journal of Nuclear …, 2012 - Soc Nuclear Med
Prostate-specific membrane antigen (PSMA) is a type II integral membrane protein
expressed on the surface of prostate cancer (PCa) cells, particularly in androgen …
expressed on the surface of prostate cancer (PCa) cells, particularly in androgen …